Fusion gene information | Fusion gene name: COL4A1-PELI1 |
Fusion gene ID: hg1282tg57162 | | Hgene | Tgene | Gene symbol | COL4A1 | PELI1 | Gene ID | 1282 | 57162 | Gene name | collagen type IV alpha 1 chain | pellino E3 ubiquitin protein ligase 1 |
Synonyms | BSVD|BSVD1|PADMAL|RATOR | - |
Cytomap | ('COL4A1')('PELI1') 13q34 | 2p14 |
Type of gene | protein-coding | protein-coding |
Description | collagen alpha-1(IV) chainCOL4A1 NC1 domainarrestencollagen IV, alpha-1 polypeptidecollagen of basement membrane, alpha-1 chain | E3 ubiquitin-protein ligase pellino homolog 1RING-type E3 ubiquitin transferase pellino homolog 1pellino homolog 1pellino-1pellino-related intracellular-signaling moleculeprotein pellino homolog 1 |
Modification date | 20200313 | 20200313 |
UniProtAcc | P02462 | . |
Ensembl transtripts involved in fusion gene | ENST00000375820, ENST00000467182, ENST00000543140, | |
Fusion gene scores | * DoF score | 13 X 15 X 8=1560 | 5 X 3 X 2=30 |
# samples | 15 | 5 |
** MAII score | log2(15/1560*10)=-3.37851162325373 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/30*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 |
Context | PubMed: COL4A1 [Title/Abstract] AND PELI1 [Title/Abstract] AND fusion [Title/Abstract] |
Most frequent breakpoint | COL4A1(110947793)-PELI1(64319982), # samples:1
|
Anticipated loss of major functional domain due to fusion event. | |
Hgene | Tgene |
COL4A1
P02462 | . |
FUNCTION: Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. {ECO:0000250|UniProtKB:P02463}.; FUNCTION: Arresten, comprising the C-terminal NC1 domain, inhibits angiogenesis and tumor formation. The C-terminal half is found to possess the anti-angiogenic activity. Specifically inhibits endothelial cell proliferation, migration and tube formation. {ECO:0000269|PubMed:10811134, ECO:0000269|PubMed:18775695}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | COL4A1 | C4551998 | Porencephaly, Type 1, Autosomal Dominant | 18 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | COL4A1 | C2673195 | Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps | 6 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | COL4A1 | C1843512 | BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE | 4 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Hgene | COL4A1 | C0018965 | Hematuria | 3 | GENOMICS_ENGLAND |
Hgene | COL4A1 | C0266548 | Axenfeld anomaly (disorder) | 3 | CTD_human;GENOMICS_ENGLAND |
Hgene | COL4A1 | C1860475 | Retinal vascular tortuosity | 3 | GENOMICS_ENGLAND |
Hgene | COL4A1 | C0011881 | Diabetic Nephropathy | 2 | CTD_human |
Hgene | COL4A1 | C0017667 | Nodular glomerulosclerosis | 2 | CTD_human |
Hgene | COL4A1 | C0017668 | Focal glomerulosclerosis | 2 | CTD_human |
Hgene | COL4A1 | C0086432 | Hyalinosis, Segmental Glomerular | 2 | CTD_human |
Hgene | COL4A1 | C0265341 | Rieger syndrome | 2 | CTD_human |
Hgene | COL4A1 | C0266484 | Schizencephaly | 2 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Hgene | COL4A1 | C0302892 | Congenital porencephaly | 2 | CTD_human |
Hgene | COL4A1 | C1280768 | Axenfeld syndrome | 2 | CTD_human |
Hgene | COL4A1 | C1867983 | PORENCEPHALY, FAMILIAL | 2 | CTD_human;ORPHANET |
Hgene | COL4A1 | C2675650 | Brain Small Vessel Disease With Axenfeld-Rieger Anomaly | 2 | CTD_human |
Hgene | COL4A1 | C2678503 | AXENFELD-RIEGER SYNDROME, TYPE 3 | 2 | CTD_human |
Hgene | COL4A1 | C3281105 | HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO | 2 | GENOMICS_ENGLAND;UNIPROT |
Hgene | COL4A1 | C3495488 | Axenfeld-Rieger syndrome | 2 | CTD_human |
Hgene | COL4A1 | C3698507 | Post-traumatic Porencephaly | 2 | CTD_human |
Hgene | COL4A1 | C3714873 | Axenfeld-Rieger Syndrome, Type 1 | 2 | CTD_human |
Hgene | COL4A1 | C4082173 | Porencephaly | 2 | CTD_human |
Hgene | COL4A1 | C4082301 | Developmental Porencephaly | 2 | CTD_human |
Hgene | COL4A1 | C0002878 | Anemia, Hemolytic | 1 | CTD_human |
Hgene | COL4A1 | C0002879 | Anemia, Hemolytic, Acquired | 1 | CTD_human |
Hgene | COL4A1 | C0002889 | Anemia, Microangiopathic | 1 | CTD_human |
Hgene | COL4A1 | C0015393 | Eye Abnormalities | 1 | CTD_human |
Hgene | COL4A1 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Hgene | COL4A1 | C0026848 | Myopathy | 1 | GENOMICS_ENGLAND |
Hgene | COL4A1 | C0027726 | Nephrotic Syndrome | 1 | CTD_human |
Hgene | COL4A1 | C0036572 | Seizures | 1 | GENOMICS_ENGLAND |
Hgene | COL4A1 | C0038454 | Cerebrovascular accident | 1 | GENOMICS_ENGLAND |
Hgene | COL4A1 | C0149931 | Migraine Disorders | 1 | GENOMICS_ENGLAND |
Hgene | COL4A1 | C0221021 | Microangiopathic hemolytic anemia | 1 | CTD_human |
Hgene | COL4A1 | C0265221 | Walker-Warburg congenital muscular dystrophy | 1 | ORPHANET |
Hgene | COL4A1 | C0270612 | Leukoencephalopathy | 1 | CTD_human |
Hgene | COL4A1 | C0338656 | Impaired cognition | 1 | GENOMICS_ENGLAND |
Hgene | COL4A1 | C0424605 | Developmental delay (disorder) | 1 | GENOMICS_ENGLAND |
Hgene | COL4A1 | C0497327 | Dementia | 1 | GENOMICS_ENGLAND |
Hgene | COL4A1 | C0557874 | Global developmental delay | 1 | GENOMICS_ENGLAND |
Hgene | COL4A1 | C1135196 | Heart Failure, Diastolic | 1 | CTD_human |
Hgene | COL4A1 | C1858991 | Childhood Ataxia with Central Nervous System Hypomyelinization | 1 | CTD_human |
Hgene | COL4A1 | C1867327 | RETINAL ARTERIES, TORTUOSITY OF | 1 | CTD_human;ORPHANET;UNIPROT |
Hgene | COL4A1 | C2733158 | Cerebral Small Vessel Diseases | 1 | GENOMICS_ENGLAND |
Hgene | COL4A1 | C2930808 | Familial vascular leukoencephalopathy | 1 | ORPHANET |
Hgene | COL4A1 | C2931870 | Familial schizencephaly | 1 | ORPHANET |
Hgene | COL4A1 | C4013035 | BRAIN SMALL VESSEL DISEASE WITH OR WITHOUT OCULAR ANOMALIES | 1 | GENOMICS_ENGLAND |
Tgene | | C0037274 | Dermatologic disorders | 1 | CTD_human |
Tgene | | C0274861 | Arsenic Poisoning, Inorganic | 1 | CTD_human |
Tgene | | C0274862 | Nervous System, Organic Arsenic Poisoning | 1 | CTD_human |
Tgene | | C0311375 | Arsenic Poisoning | 1 | CTD_human |
Tgene | | C0751851 | Arsenic Encephalopathy | 1 | CTD_human |
Tgene | | C0751852 | Arsenic Induced Polyneuropathy | 1 | CTD_human |